Study of the safety and immunogenicity of 20vPnC and influenza vaccine administered at the same visit or separately
|Treatment||Saline, Influenza vaccine, Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)|
|Clinical Study Identifier||NCT04526574|
|Last Modified on||16 December 2020|
Select a piece of text and start making personal notes.
Congrats! You have your own personal workspace now.